We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
A surgical patch technology developed at Oxford has been featured on the BBC.
Oxford Immunotec – a 2002 Isis spin-out – has raised US$64 million in an IPO on America’s Nasdaq stock exchange. The Abingdon-based company sells diagnostic tests for latent tuberculosis infection, T-SPOT®.TB.
Immunocore Limited, the Oxford based biotechnology company developing novel biological drugs to treat cancer and viral disease has announced the achievement of its first milestone in its research and licensing agreement with GlaxoSmithKline.
Oxford University Innovation spin-outs, Oxford Gene Technology and OrganOx have won an award each at the OBN Annual Awards Dinner held on 1st October. The OBN is a membership organisation supporting and bringing together the UK’s emerging life science R&D companies, their corporate partners and investors.
As the technology commercialisation company of Oxford University, Oxford University Innovation, celebrates its 25th anniversary, it also looks back on 101 companies that originate from Isis. Oxford Biotrans, the 101st company, will commercialise new routes to high-value chemicals using patented enzyme technology.
Spanish company, Torus Software Solutions, working with Isis Enterprise, has won a competition run by the UK Trade & Investment. The UKTI Spain Technology Competition was aimed at helping Spanish businesses expand into the UK. Torus’ victory will reward it with a visit to the UK in which meetings will be set up between the management team and key contacts in their industry. The winners will also be provided entry into a business event of their choice in Britain. Isis Enterprise (IE) is the innovation management consultancy business of Oxford University Innovation, the technology transfer arm of the University of Oxford.
A second Isis joint venture company in China was created in June. In addition to providing technology transfer services between the rest of the world and China.
This week, an Oxford start-up released a new android app that connects small, independent businesses to their local customers. OXGEOS (Oxford Geo Social Technologies), coming out of Oxford University Innovation, the Technology Transfer Company of the University of Oxford, has released their app, called LovesVouchers, on the Google Play Store. LovesVouchers is free to download and for as little as £2.50 a small business can start attracting customers via discount vouchers.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, today announced it has entered into a partnership with GlaxoSmithKline (GSK) for multiple novel targets not addressable using antibody-based technologies. This is Immunocore’s second major partnership this year.
A new independent, industry-focused university is being established in Gujarat, India, under the aegis of Whistling Group. The Whistling Group will draw on expert advice from Oxford University Innovation Ltd, a wholly owned subsidiary of the University of Oxford, and from various members of the University of Oxford acting in a consultancy capacity.
